# Design principles

The Well-Architected Framework identifies a set of general design principles to facilitate
good design in the cloud. In addition, the following design principles should also be considered
for designing and operating life sciences workloads.

The development of drug therapies is highly regulated for safety, efficacy, and security of
drug therapies. In the United States, the Federal Drug Administration (FDA) mandates a series of
Good Practices (GxP) which covers practices related to laboratories, clinical development, and
manufacturing. This requires careful management of data integrity throughout the scenarios.
Drugs are represented by data including the related research, biological data, genomic data,
data gathered through clinical trials, data related to its manufacture, and real world data
(RWD) collected after they are used in real world clinical settings. Data collaboration is also
a common design principle, as there are several organizations involved including research
institutions, governmental regulators, contract research organizations (CROs), and healthcare
payors and providers.

- **Implement strong security foundations:** Follow industry best
  practices as detailed in the [AWS Well-Architected Security
  Pillar whitepaper](../security-pillar/welcome.md "../security-pillar/welcome.md"). Address GxP requirements that affect IT both as a source of
  requirements for workloads and as a set of controls over how those workloads should be built
  and operated.
- **Adhere to regulatory frameworks:** Become familiar with
  regulatory frameworks based on geography and industry best practices such as ISO 27001 and
  HIPAA. Create a controlled infrastructure with a prescribed account vending process,
  incorporating a layered model emphasizing infrastructure qualification and tooling
  verification. Shift from document-based to data-driven processes, prioritizing data
  integrity to align with FDA requirements (21 CFR Part 11 and ALCOA+). Implement continuous
  adhrerence through automated audit controls using defined configurations, compliance packs,
  and regular auditing to create a comprehensive, trustworthy environment that can integrate
  with a data lake.
- **Develop robust quality management systems:** Effective
  quality management (QM) and quality risk managment (QRM) is mandatory in the
  highly-regulated pharmaceutical, biotechnology, and medical device industries. Integrate
  effective QM and QRM practices into information technology systems to improve product
  quality, patient safety, and regulatory adherence throughout the product lifecycle.
- **Design comprehensive data management strategies:** Begin by
  reviewing the [Data Analytics
  Lens](../analytics-lens/analytics-lens.md "../analytics-lens/analytics-lens.md"). Address complexity based on the type of data created, collected, and stored,
  and consider the complete lifecycle of that data in relation to project phases. For
  geographically distributed operations such as multi-site clinical trials, decentralized
  research, or global manufacturing, implement distributed file systems that enable edge
  compute capabilities while maintaining centralized governance. Design architectures that
  process and validate data locally at clinical sites, manufacturing facilities, or research
  labs to optimize performance and reduce latency, while synchronizing to central repositories
  for regulatory adherence, audit, and collaboration. Balance local autonomy with centralized
  security controls, verifying data integrity and regulatory adherence across edge locations
  through encrypted data transfer, access controls, and comprehensive audit trails.
- **Enable secure cross-organizational collaboration:** Implement
  robust governance frameworks, audit trails, access controls, and long-term archival plans
  for managing data throughout its entire lifecycle. Adopt standardized formats (like CDISC,
  FHIR, and ISA-95) to promote collaboration between teams and systems. Consider each phase of
  the project from design through closeout while verifying that data can be securely shared
  with research institutions, regulators, and contract research organizations (CROs) while
  adhering to regulations. For more detail, see [Data
  lifecycle](data-lifecycle.md "data-lifecycle.md").
